MARKET

ABVC

ABVC

Abvc Biopharma Inc
NASDAQ
0.6499
+0.0499
+8.32%
After Hours: 0.6700 +0.0201 +3.09% 16:06 03/20 EDT
OPEN
0.6421
PREV CLOSE
0.6000
HIGH
0.6900
LOW
0.6373
VOLUME
21.99K
TURNOVER
0
52 WEEK HIGH
3.130
52 WEEK LOW
0.5000
MARKET CAP
21.35M
P/E (TTM)
-0.9373
1D
5D
1M
3M
1Y
5Y
BRIEF-ABVC BioPharma Provides Vitargus Update On Phase II Site Initiation Visit Conducted At Srinagarind Hospital In Thailand
Reuters · 23h ago
ABVC Biopharma Says Taiwan Health Ministry Approves Dietary Supplement Tablets
ABVC Biopharma Says Taiwan Health Ministry Approves Dietary Supplement Tablets
MT Newswires · 03/14 10:31
ABVC BioPharma Provides 2023 Pipeline Update
Benzinga · 02/28 13:41
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 02/23 21:31
ABVC BioPharma ABV-1505 ADHD Phase IIa Results Presented At 2023 APSARD Conference
Benzinga · 01/19 13:42
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga · 01/06 18:16
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 01/06 13:05
Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket
Benzinga · 01/06 13:00
More
About ABVC
ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on development of drugs and medical devices, all of which are derived from plants. The Company develops its pipeline by tracking medical discoveries or medical device technologies in research institutions in the Asia-Pacific region. Its pipeline includes ABV-1501, ABV-1504, ABV-1505, ABV-1703, ABV-1601, ABV-1701 and ABV-2002. ABV-1504 is a botanical reuptake inhibitor that targets norepinephrine to treat major depressive disorder (MDD). It is developing ABV-1505 for treating attention deficit hyperactivity disorder (ADHD). It has developed ABV-1601 for treating depression in cancer patients. ABV-1501 is a combination therapy for triple negative breast cancer (TNBC). ABV-1701 is a vitreous substitute for vitrectomy. ABV-1703 is a drug for advanced inoperable or metastatic pancreatic cancer. ABV-2002 is a corneal storage media consisting of a specific polymer formulated to protect ocular tissues from osmolarity.

Webull offers kinds of ABVC Biopharma Inc stock information, including NASDAQ:ABVC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABVC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ABVC stock methods without spending real money on the virtual paper trading platform.